Retina Implant AG, a Reutlingen, Germany firm, obtained European regulatory approval for its Alpha AMS subretinal implant for people that have become blind due to retinitis pigmentosa. The new device is an upgrade to the Alpha IMS that was cleared in Europe back in 2013.
The Alpha AMS features 1,600 pixels, which is 100 more than the Alpha IMS mo (Read more...)